MERCK EBOLA VACCINE CLINICAL TRIAL SUSPENDED IN GENEVA AFTER SIDE EFFECTS: MAJOR SETBACK FOR WHO

The unnecessary deaths and damage when safer, simpler and cost effective solutions exist is pathological.

Eugenics and pandemics

Trials on a new Ebola vaccine developed by Merck and NewLink were suspended by Geneval University Hospital after four volunteers reported unexpected side effects.

Four participants reported join pain ten to fourteen days after an injection.

Professor Laurent Kaiser said that many of the volunteers for the Merck NewLink Ebola vaccine trial in Geneva were doctors, and so able to report side effects more precisely.

Kaiser noted other clinical trials had not reported side effects but they had given volunteers smaller doses and also had yet to reach the 10 to 14 day mark when the side affects appeared.

The trials will resume on January on up to 15 of the original 59 volunteers, after checks to ensure that the joint pain symptoms in hands and feet were temporary and benign.

The trial suspension is a setback for WHO plans to give the experimental Canadian and GSK Ebola vaccine to thousands of…

View original post 33 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s